Agilon Health, Inc. (NYSE:AGL) Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC lifted its position in Agilon Health, Inc. (NYSE:AGL - Free Report) by 1,271.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 144,189 shares of the company's stock after acquiring an additional 133,674 shares during the period. SG Americas Securities LLC's holdings in Agilon Health were worth $624,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Captrust Financial Advisors boosted its holdings in shares of Agilon Health by 10.9% in the 4th quarter. Captrust Financial Advisors now owns 35,485 shares of the company's stock valued at $67,000 after acquiring an additional 3,494 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Agilon Health by 2.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company's stock valued at $393,000 after purchasing an additional 5,107 shares during the period. MetLife Investment Management LLC lifted its position in Agilon Health by 4.0% during the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company's stock valued at $332,000 after purchasing an additional 6,762 shares during the period. Symphony Financial Services Inc. boosted its holdings in Agilon Health by 44.3% in the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company's stock valued at $44,000 after purchasing an additional 7,058 shares during the last quarter. Finally, Signaturefd LLC grew its position in Agilon Health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after purchasing an additional 8,467 shares during the period.

Agilon Health Trading Down 3.0%

NYSE:AGL traded down $0.07 during trading hours on Friday, reaching $2.12. 3,120,954 shares of the company were exchanged, compared to its average volume of 4,982,446. The firm has a market cap of $875.50 million, a PE ratio of -3.58 and a beta of 0.14. Agilon Health, Inc. has a twelve month low of $1.50 and a twelve month high of $7.73. The stock's 50-day moving average is $3.03 and its 200-day moving average is $3.21.

Agilon Health (NYSE:AGL - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.04. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.50 billion. Agilon Health had a negative net margin of 4.04% and a negative return on equity of 45.47%. The company's revenue for the quarter was down 4.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.02) EPS. As a group, research analysts anticipate that Agilon Health, Inc. will post -0.59 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AGL. TD Cowen boosted their price objective on Agilon Health from $3.50 to $6.00 and gave the company a "hold" rating in a report on Tuesday, April 15th. Robert W. Baird reduced their price target on Agilon Health from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Needham & Company LLC reissued a "hold" rating on shares of Agilon Health in a report on Friday, March 21st. Cowen reaffirmed a "hold" rating on shares of Agilon Health in a research note on Tuesday, April 15th. Finally, Citigroup raised shares of Agilon Health from a "neutral" rating to a "buy" rating and lifted their target price for the company from $3.25 to $5.00 in a report on Friday, April 25th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $4.79.

Agilon Health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.